National Kidney Foundation Research Funding Opportunity
New York, NY (November 23, 2003) - The National Kidney Foundation (NKF) is again accepting grant proposals to support research in the area of primary nocturnal enuresis. The Enuresis Research Grant, sponsored in part by Aventis Pasteur Pharmaceuticals, was created to stimulate research to contribute to the understanding and cure of this condition. This past year, two applicants received a grant award for the research they will be conducting during 2003-2004:
Seth Schulman, MD, from The Children's Hospital of Philadelphia will be evaluating the efficacy of Desmopressin Acetate in combination with nocturnal enuresis alarm in children with recalcitrant primary nocturnal enuresis.
Paul Austin, MD, from Washington University School of Medicine will be determining the efficacy of combination therapy using desmopressin and an anticholinergic (Ditropan XL) in treating children with refractory primary monosymptomatic nocturnal enuresis to desmopressin alone.
To apply for this grant, applicants must have at least two years of experience as an allied healthcare professional, Ph.D. or M.D. in the areas of pediatrics, pediatric urology, pediatric nephrology, child psychology, behavioral medicine, neurology or continence nursing. The grant may be used toward basic, clinical, epidemiological or behavioral research. The typical grant is $12,500 but up to $35,000 may be awarded.
Letter of Intent Deadline:
January 30, 2004
February 27, 2004
Announcement of Recipients:
July 1, 2004-June 30, 2005
For more information about the NKF/Aventis Pasteur Enuresis Research Grant click here or contact Dolph Chianchiano at 800/889-9559, email@example.com. Letters of intent should be mailed to: National Kidney Foundation Office of Scientific & Public Policy, 11911 North Fort Myer Drive, Suite 801, Arlington, VA 22209, USA. Attn: Enuresis Research Grant.